Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor-Induced Thyroiditis

By sjmartinez • September 22, 2023

Chen DH, Lenz HJ, Lechner MG, Angell TE. Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor-Induced Thyroiditis. AACE Clin Case Rep. 2023 Jun 3;9(5):162-165. doi: 10.1016/j.aace.2023.05.009. PMID: 37736314; PMCID: PMC10509378.

Tags: efficacy, Endocrinology, immune checkpoint inhibitors, immune-related adverse events, papillary thyroid carcinoma, Publications, thyroiditis

Stephanie Smooke Praw, MD Appointed Interim Chief of the UCLA Division of Endocrinology

The UCLA Department of Medicine is delighted to announce that Stephanie Smooke Praw, MD has been appointed interim chief of the UCLA Division of Endocrinology, expanding upon her[...]

Diet, nutrition, and hormone therapy for prostate cancer: a systematic review with implications for future interventions

Pahulu I, Calumpit M, Tominez P, Shih JJ, Ebrahimi S, Deville NV, Samoa R, Moin T, Sedrak MS, Valle LF, Steinberg M, Kishan AU, Ganz[...]

The malate-aspartate shuttle supports thermogenic lipid mobilization in brown adipocytes

Veliova M, Ferreira CM, Montales KP, Villalobos F, Brownstein AJ, Acín-Pérez R, Ferreira GS, Jones AE, Stiles L, Divakaruni AS, Liesa M, Shirihai OS, Oliveira[...]